Quote | Checkmate Pharmaceuticals Inc. (NASDAQ:CMPI)
Last: | $10.50 |
---|---|
Change Percent: | 0.0% |
Open: | $10.49 |
Close: | $10.50 |
High: | $10.5 |
Low: | $10.48 |
Volume: | 63,651 |
Last Trade Date Time: | 05/30/2022 04:53:53 pm |
News | Checkmate Pharmaceuticals Inc. (NASDAQ:CMPI)
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules • $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” ...
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat c...
Message Board Posts | Checkmate Pharmaceuticals Inc. (NASDAQ:CMPI)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CMPI News Article - Why Adaptimmune Therapeutics, Agenus, and Sorrento Therapeutics Po | whytestocks | investorshangout | 04/19/2022 7:55:53 PM |
whytestocks: $CMPI News Article - Why Checkmate Pharmaceuticals Stock Is Rocketing Higher Today | whytestocks | investorshangout | 04/19/2022 7:15:53 PM |
Geez, I simply congratulated longs but now....... | hedge_fun | investorshub | 04/19/2022 6:53:05 PM |
How much PROFIT did you make, Dude??? Inspire | Just-Keep-Trying | investorshub | 04/19/2022 6:26:26 PM |
whytestocks: $CMPI News Article - Hot Penny Stocks to Buy? 3 to Watch As CMPI Stock Shoots Up 320% | whytestocks | investorshangout | 04/19/2022 2:00:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkmate Pharmaceuticals Inc. Company Name:
CMPI Stock Symbol:
NASDAQ Market:
Ad-hoc announcement pursuant to Article 53 of the SIX listing rules • $2.5 million of milestone to be paid to XOMA Corporation under royalty agreement SCHLIEREN (ZURICH), Switzerland, June 02, 2022 (GLOBE NEWSWIRE) -- Kuros Biosciences AG (“Kuros” ...
CAMBRIDGE, Mass., May 26, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company focused on developing its proprietary technology to harness the power of the immune system to combat c...
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary technology to harness the power of the immune system to combat cancer, today an...